| Issue Date | Title | Author(s) |
| 2022-07-29 | Clinical impact of whole-genome sequencing in patients with early-onset dementia. | Huq, AJ; Thompson, B; Bennett, MF; Bournazos, A; Bommireddipalli, S; Gorelik, A; Schultz, J; Sexton, A; Purvis, R; West, K; Cotter, M; Valente, G; Hughes, A; Riaz, M; Walsh, M; Farrand, S; Loi, SM; Kilpatrick, T; Brodtmann, A; Darby, D; Eratne, D; Walterfang, M; Delatycki, MB; Storey, E; Fahey, M; Cooper, S; Lacaze, P; Masters, CL; Velakoulis, D; Bahlo, M; James, PA; Winship, I |
| 2022-07 | Real world outcomes and implementation pathways of exome sequencing in an adult genetic department. | Walsh, M; West, K; Taylor, JA; Thompson, BA; Hopkins, A; Sexton, A; Ragunathan, A; Verma, KP; Panetta, J; Matotek, E; Fahey, MC; Christie, M; Winship, IM; Trainer, AH; James, PA |
| 2021-08 | Genetic testing in dementia-A medical genetics perspective. | Huq, AJ; Sexton, A; Lacaze, P; Masters, CL; Storey, E; Velakoulis, D; James, PA; Winship, IM |
| 2021-11 | Suicide in frontotemporal dementia and Huntington disease: analysis of family-reported pedigree data and implications for genetic healthcare for asymptomatic relatives. | Sexton, A; West, K; Gill, G; Wiseman, A; Taylor, J; Purvis, R; Fahey, M; Storey, E; Walsh, M; James, P |
| 2022-02-01 | Metaphors and why these are important in all aspects of genetic counseling. | Sexton, A; James, PA |
| 2017-05 | Diagnostic and cost utility of whole exome sequencing in peripheral neuropathy. | Walsh, M; Bell, KM; Chong, B; Creed, E; Brett, GR; Pope, K; Thorne, NP; Sadedin, S; Georgeson, P; Phelan, DG; Day, T; Taylor, JA; Sexton, A; Lockhart, PJ; Kiers, L; Fahey, M; Macciocca, I; Gaff, CL; Oshlack, A; Yiu, EM; James, PA; Stark, Z; Ryan, MM; Melbourne Genomics Health Alliance, |
| 2019-10 | Living with Hereditary Haemorrhagic Telangiectasia: stigma, coping with unpredictable symptoms, and self-advocacy. | Sexton, A; Gargan, B; Taylor, J; Bogwitz, M; Winship, I |
| 2022-11-17 | Assessing the acceptability, feasibility, and usefulness of a psychosocial screening tool to patients and clinicians in a clinical genetics service in Australia. | Monohan, K; Purvis, R; Sexton, A; Kentwell, M; Thet, M; Stafford, L; Forrest, L |
| 2020-08 | "It wasn't just for me": Motivations and implications of genetic testing for women at a low risk of hereditary breast and ovarian cancer syndrome. | Gill, G; Beard, C; Storey, K; Taylor, S; Sexton, A |
| 2020-08 | Communication about spinal muscular atrophy and genetic risk within families: An Australian pilot study. | Pieper, E; Sexton, A; Ryan, MM; Forbes, R |
